Kenvue Inc. closed 5.19% short of its 52-week high of $24.46, which the company achieved on November 26th.

With a market cap of $42.7 billion, Kenvue Inc. (KVUE) operates as a consumer health company in the United States and ...

Kenvue Inc. closed 8.95% below its 52-week high of $24.46, which the company achieved on November 26th.

The maker of Tylenol, a spinoff of J&J, has underperformed. But Kenvue could bounce back thanks to help from activist ...

The board of Kenvue Inc. ( NYSE:KVUE ) has announced that it will pay a dividend of $0.205 per share on the 28th ...

Kenvue (KVUE) announced a five-year collaboration with Microsoft (MSFT) which aims to establish a strong foundation for transforming digital ...

In this article, we are going to take a look at where Kenvue Inc. (NYSE:KVUE) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in ...

Kenvue Inc., has announced a five-year collaboration with Microsoft which aims to transform digital operations through ...

Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong ...

According to Grand View Research, the global cosmetics industry has a market size of around $295.95 billion as of 2023. It is expected to grow at a compound annual growth rate of 6.1% between 2024 ...

Redburn Atlantic initiated coverage of Kenvue (KVUE) with a Neutral rating and $23.50 price target The company’s first two years as a public ...

The collaboration aims to establish a strong foundation for transforming digital operations through advanced AI technologies.